Walleye Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Walleye Trading’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-150,000	Closed	-$7.87M	–	5231
2020 Q3	$7.87M	Buy	+150,000	New	+$6.21M	0.04%	370
2017 Q1	–	Sell	-5,700	Closed	-$86K	–	5336
2016 Q4	$86K	Buy	+5,700	New	+$75.3K	﹤0.01%	3336

Walleye Trading's MNTA Position: Q4 2020 in Review

Walleye Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 150,000 shares — an estimated $7.87M sold.

Walleye Trading first reported a position in MNTA in Q4 2016 and held it in 2 quarters. The position peaked at $7.87M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Walleye Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Walleye Trading sold 150,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $7.87M.
Walleye Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and held it in 2 quarters.
Walleye Trading's Momenta Pharmaceuticals, Inc. position peaked at $7.87M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.